137 related articles for article (PubMed ID: 11453376)
1. Serum cortisol response to transsphenoidal surgery for Cushing disease.
Simmons NE; Alden TD; Thorner MO; Laws ER
J Neurosurg; 2001 Jul; 95(1):1-8. PubMed ID: 11453376
[TBL] [Abstract][Full Text] [Related]
2. Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test.
Chen JC; Amar AP; Choi S; Singer P; Couldwell WT; Weiss MH
J Neurosurg; 2003 May; 98(5):967-73. PubMed ID: 12744355
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease.
Rollin GA; Ferreira NP; Junges M; Gross JL; Czepielewski MA
J Clin Endocrinol Metab; 2004 Mar; 89(3):1131-9. PubMed ID: 15001598
[TBL] [Abstract][Full Text] [Related]
4. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts.
McLaughlin N; Cohan P; Barnett P; Eisenberg A; Chaloner C; Kelly DF
World Neurosurg; 2013 Nov; 80(5):569-75. PubMed ID: 22902358
[TBL] [Abstract][Full Text] [Related]
5. Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients.
Shimon I; Ram Z; Cohen ZR; Hadani M
Neurosurgery; 2002 Jul; 51(1):57-61; discussion 61-2. PubMed ID: 12182435
[TBL] [Abstract][Full Text] [Related]
6. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
Chee GH; Mathias DB; James RA; Kendall-Taylor P
Clin Endocrinol (Oxf); 2001 May; 54(5):617-26. PubMed ID: 11380492
[TBL] [Abstract][Full Text] [Related]
7. Use of the histological pseudocapsule in surgery for Cushing disease: rapid postoperative cortisol decline predicting complete tumor resection.
Monteith SJ; Starke RM; Jane JA; Oldfield EH
J Neurosurg; 2012 Apr; 116(4):721-7. PubMed ID: 22283193
[TBL] [Abstract][Full Text] [Related]
8. Intra- and postoperative plasma ACTH concentrations in patients with Cushing's disease cured by transsphenoidal pituitary surgery.
Czirják S; Bezzegh A; Gál A; Rácz K
Acta Neurochir (Wien); 2002 Oct; 144(10):971-7; discussion 977. PubMed ID: 12382124
[TBL] [Abstract][Full Text] [Related]
9. Predicting relapse after transsphenoidal surgery for Cushing's disease.
Toms GC; McCarthy MI; Niven MJ; Orteu CH; King TT; Monson JP
J Clin Endocrinol Metab; 1993 Feb; 76(2):291-4. PubMed ID: 8432771
[TBL] [Abstract][Full Text] [Related]
10. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
[TBL] [Abstract][Full Text] [Related]
11. Outcome of Microscopic Transsphenoidal Surgery in Cushing Disease: A Case Series of 96 Patients.
Shirvani M; Motiei-Langroudi R; Sadeghian H
World Neurosurg; 2016 Mar; 87():170-5. PubMed ID: 26704208
[TBL] [Abstract][Full Text] [Related]
12. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[TBL] [Abstract][Full Text] [Related]
13. Assessment of endocrine function after transsphenoidal surgery for Cushing's disease.
McCance DR; Gordon DS; Fannin TF; Hadden DR; Kennedy L; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 1993 Jan; 38(1):79-86. PubMed ID: 8382119
[TBL] [Abstract][Full Text] [Related]
14. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.
Fomekong E; Maiter D; Grandin C; Raftopoulos C
Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645
[TBL] [Abstract][Full Text] [Related]
15. Cushing disease.
Oldfeld EH
J Neurosurg; 2003 May; 98(5):948-51; discussion 951. PubMed ID: 12744352
[No Abstract] [Full Text] [Related]
16. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
Flitsch J; Knappe UJ; Lüdecke DK
Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of prognosis factors in the cure of Cushing's disease surgically treated via a +septotransphenoidal approach].
González JD; Gómez JM; Montanya E; Carrera MJ; Villabona C; Acebes JJ; Soler J
An Med Interna; 1997 Jul; 14(7):337-40. PubMed ID: 9410118
[TBL] [Abstract][Full Text] [Related]
18. Transsphenoidal surgery in Cushing disease: 10 years of experience in 34 consecutive cases.
Höybye C; Grenbäck E; Thorén M; Hulting AL; Lundblad L; von Holst H; Anggård A
J Neurosurg; 2004 Apr; 100(4):634-8. PubMed ID: 15070117
[TBL] [Abstract][Full Text] [Related]
19. Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease.
Esposito F; Dusick JR; Cohan P; Moftakhar P; McArthur D; Wang C; Swerdloff RS; Kelly DF
J Clin Endocrinol Metab; 2006 Jan; 91(1):7-13. PubMed ID: 16234305
[TBL] [Abstract][Full Text] [Related]
20. Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation.
Marko NF; Gonugunta VA; Hamrahian AH; Usmani A; Mayberg MR; Weil RJ
J Neurosurg; 2009 Sep; 111(3):540-4. PubMed ID: 19326985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
